Therefore, our results suggest a novel mechanism of DUB dysregulation involving CYLD, A20, and OTUD7B in gastric cancer and provide a functionally and clinically relevant epigenetic mechanism in cancer progression. The gene discussed is CYLD; the disease is cancer.